Neuroone Medical Technologies Corp (NASDAQ:NMTC)

Delayed Data
As of Sep 22
 +0.0128 / +1.41%
Today’s Change
Today|||52-Week Range

Stock Price Forecast

The 2 analysts offering 12-month price forecasts for Neuroone Medical Technologies Corp have a median target of 2.10, with a high estimate of 2.20 and a low estimate of 2.00. The median estimate represents a +128.01% increase from the last price of 0.92.

Analyst Recommendations

The current consensus among 2 polled investment analysts is to Buy stock in Neuroone Medical Technologies Corp. This rating has held steady since March, when it was unchanged from a Buy rating.Move your mouse over past
months for detail


Earnings and Sales Forecasts

Current Quarter

Earnings per Share
Reporting Date
Dec 13

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 25.00%
Growthannually -3.17%


Growthquarterly 6.68%
Growthannually 45.26%
Key to the earnings and sales forecast charts.